https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/adjustment-for-amortization https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/amortization-of-advance-royalty https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/amount-of-dilutive-securities-esop-convertible-preferred-stock https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/billed-contract-receivables https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cash-uninsured-amount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/convertible-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/convertible-debt-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cost-of-services https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/customer-deposits-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-interest-rate https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debtor-reorganization-items-gain-loss-on-settlement-of-other-claims-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debtor-reorganization-items-legal-and-advisory-professional-fees https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/debtor-reorganization-items-revaluation-of-assets-and-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/derivative-financial-instruments-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/discontinued-operation-amount-of-other-income-loss-from-disposition-of-discontinued-operations-before-income-tax https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/discontinued-operation-gain-loss-from-disposal-of-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/discontinued-operation-tax-effect-of-discontinued-operation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/discontinued-operation-tax-effect-of-income-loss-from-disposal-of-discontinued-operation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-accounts-notes-and-loans-receivable-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-goodwill https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-gross-profit-loss https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-intangible-assets-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-expense https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-other-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-other-current-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-other-current-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-other-noncurrent-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/dividends-preferred-stock https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/due-from-related-parties-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/eps https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/equity-method-investment-aggregate-cost https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gain-loss-on-sale-of-debt-investments https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gains-losses-on-restructuring-of-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-tax-expense-benefit-intraperiod-tax-allocation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/increase-decrease-in-unbilled-receivables https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/interest-and-debt-expense https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/inventory https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/legal-settlement-proceeds https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/liabilities-subject-to-compromise https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/minority-interest https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/net-income https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/new-accounting-pronouncement-or-change-in-accounting-principle-cumulative-effect-of-change-on-equity-or-net-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/noncontrolling-interest-in-variable-interest-entity https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/notes-payable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-income-tax-expense-benefit https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-long-term-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-long-term-debt-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/payments-for-royalties https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/pro-forma-weighted-average-shares-outstanding-diluted https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-secured-notes-payable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/public-float https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/receivables-long-term-contracts-or-programs https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/reorganization-items https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/revenue https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sales-revenue-services-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-prer14a https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/sec-filings-revoked https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/share-price https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/shares-issued-2 https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-issued-shares-issued-value-employee-stock-ownership-plan https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/treasury-stock-value https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/unbilled-contracts-receivable https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/unbilled-receivables-not-billable-at-balance-sheet-date https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/variable-interest-entity-consolidated-carrying-amount-assets-and-liabilities-net https://stock.noler.com/us/stock/accentia-biopharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted